| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Colorectal Cancer | |||||
| Metastatic Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Colorectal Neoplasms | |||||
| Neoplasm Metastasis | |||||
| 3 | More general conditions related to this trial | ||||
| Colonic Diseases | |||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Intestinal Diseases | |||||
| Intestinal Neoplasms | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Neoplastic Processes | |||||
| Pathologic Processes | |||||
| Rectal Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| adjuvant therapy | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Antibodies | |||||
| Antibodies, Monoclonal | |||||
| Immunoglobulin Idiotypes | |||||
| 6 | More general drug interventions related to this trial | ||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 7 | Sponsors listed in this trial | ||||
| Cancer and Leukemia Group B | |||||
| National Cancer Institute (NCI) | |||||
|
